NY S 4676
in committeeAdds xylazine to the depressants designated as controlled substances
New York · 2025-2026 Regular Session · upper
Description
Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
- Introduced
- —
- Status date
- —
- Latest action
- 2026-01-07 — REFERRED TO HEALTH
- Bill type
- bill
- Last updated
- —
Sponsors
- Dean Murrayprimary
- Jake Ashbycosponsor
- George Borrellocosponsor
- Patricia Canzoneri-Fitzpatrickcosponsor
- Patrick M. Gallivancosponsor
- Pamela Helmingcosponsor
- Monica Martinezcosponsor
- Jack M. Martinscosponsor
- Mario Matteracosponsor
- Anthony H. Palumbocosponsor
- Steve Rhoadscosponsor
- James Tediscocosponsor
- William Webercosponsor
- Alexis Weikcosponsor
Committees
Not provided by source.
Action timeline
2025-02-11
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
Versions
- S4676Compare
Documents
- application/pdf(no extracted text yet)
- text/html(no extracted text yet)
Votes
Not provided by source.
Related bills
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 4676. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.